Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Obstetrics and Gynecology Reports
Published in: Current Obstetrics and Gynecology Reports 3/2019

01-09-2019 | Ultrasound | Aberrant Placentation: Contemporary Management of Placenta Accreta (E Jauniaux, Section Editor)

Prenatal Ultrasound Imaging for Placenta Accreta Spectrum (PAS): a Practical Guide

Authors: Frederic Chantraine, Sally L. Collins

Published in: Current Obstetrics and Gynecology Reports | Issue 3/2019

Login to get access

Abstract

Purpose of Review

Placenta accreta spectrum (PAS) is a rare pregnancy complication with an increasing incidence worldwide. PAS can cause serious maternal morbidity and even mortality at delivery. Ultrasound (US) is an excellent imaging modality for the diagnosis of PAS, but it must be used correctly and there is little standardised training in placental imaging available. The aim of this paper is to discuss US screening for PAS and provide practical advice on its use for antenatal diagnosis.

Recent Findings

Screening for PAS in a high-risk population (history of previous caesarean delivery (CD) and an anterior low-lying/praevia placenta) is possible in well-trained hands with high sensitivity and specificity. This can be performed in the first trimester but usually occurs around 24–28 weeks after the routine anomaly US. A detailed examination of the placental bed using the US signs defined by EW-AIP with an adequately filled bladder enables the operator to produce a detailed report fully outlining the anticipated findings at delivery. This facilitates an appropriate multi-disciplinary team (MDT) approach which is the goal for optimal PAS management.

Summary

Women with a history of previous CD and an anterior low-lying/praevia placenta need a detailed examination of the placenta by an experienced operator. The US examination should be undertaken systematically, and the risk factors and US signs reported in a way which is useful to the MDT.
Appendix
Available only for authorised users
Literature
1.
Luke RK, Sharpe JW, Greene RR. Placenta accreta: the adherent or invasive placenta. Am J Obstet Gynecol. 1966;95:660–8.CrossRefPubMed
2.
Chantraine F, Braun T, Gonser M, Henrich W, Tutschek B. Prenatal diagnosis of abnormally invasive placenta reduces maternal peripartum hemorrhage and morbidity. Acta Obstet Gynecol Scand. 2013;92(4):439–44.CrossRefPubMed
3.
Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One. 2012;7(12):e52893.CrossRefPubMedPubMedCentral
4.
Morlando M, Sarno L, Napolitano R, Capone A, Tessitore G, Maruotti GM, et al. Placenta accreta: incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstet Gynecol Scand. 2013;92(4):457–60.CrossRefPubMed
5.
Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a. BJOG. 2019;126(1):e1–e48.CrossRef
6.
D’Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013;42(5):509–17.CrossRefPubMed
7.
Society of Gynecologic O, American College of O, Gynecologists, the Society for Maternal-Fetal M, Cahill AG, Beigi R, et al. Placenta accreta spectrum. Am J Obstet Gynecol. 2018;219(6):B2–B16.CrossRef
8.
Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140(3):274–80.CrossRefPubMed
9.
Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217(1):27–36.CrossRefPubMed
10.
Panaiotova J, Tokunaka M, Krajewska K, Zosmer N, Nicolaides KH. Screening for morbidly adherent placenta in early pregnancy. Ultrasound Obstet Gynecol. 2019;53(1):101–6.CrossRefPubMed
11.
D’Antonio F, Timor-Tritsch IE, Palacios-Jaraquemada J, Monteagudo A, Buca D, Forlani F, et al. First-trimester detection of abnormally invasive placenta in high-risk women: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(2):176–83.CrossRefPubMed
12.
Jurkovic D, Hillaby K, Woelfer B, Lawrence A, Salim R, Elson CJ. First-trimester diagnosis and management of pregnancies implanted into the lower uterine segment Cesarean section scar. Ultrasound Obstet Gynecol. 2003;21(3):220–7.CrossRefPubMed
13.
Cali G, Forlani F, Timor-Tritsch IE, Palacios-Jaraquemada J, Minneci G, D’Antonio F. Natural history of Cesarean scar pregnancy on prenatal ultrasound: the crossover sign. Ultrasound Obstet Gynecol. 2017;50(1):100–4.CrossRefPubMed
14.
Cali G, Forlani F, Minneci G, Foti F, Di Liberto S, Familiari A, et al. First-trimester prediction of surgical outcome in abnormally invasive placenta using the cross-over sign. Ultrasound Obstet Gynecol. 2018;51(2):184–8.CrossRefPubMed
15.
Cali G, Timor-Tritsch IE, Palacios-Jaraquemada J, Monteaugudo A, Buca D, Forlani F, et al. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(2):169–75.CrossRefPubMed
16.
Birch Petersen K, Hoffmann E, Rifbjerg Larsen C, Svarre Nielsen H. Cesarean scar pregnancy: a systematic review of treatment studies. Fertil Steril. 2016;105(4):958–67.CrossRefPubMed
17.
Zosmer N, Fuller J, Shaikh H, Johns J, Ross JA. Natural history of early first-trimester pregnancies implanted in Cesarean scars. Ultrasound Obstet Gynecol. 2015;46(3):367–75.CrossRefPubMed
18.
Timor-Tritsch IE, D'Antonio F, Calí G, Palacios-Jaraquemada J, Meyer J, Monteagudo A. Early first-trimester transvaginal ultrasound is indicated in pregnancy after previous Cesarean delivery: should it be mandatory? Ultrasound Obstet Gynecol. 2019. https://​doi.​org/​10.​1002/​uog.​20225.
19.
• Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218(1):75–87 A very good comparison between the pathophysiology of PAS and the corresponding US signs.CrossRefPubMed
20.
•• Maynard H, Zamudio S, Jauniaux E, Collins SL. The importance of bladder volume in the ultrasound diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2018;140(3):332–7 This study clearly demonstrates the importance of performing US with a filled bladder when there is suspicion of PAS. CrossRefPubMed
21.
•• Collins SL, Ashcroft A, Braun T, Calda P, Langhoff-Roos J, Morel O, et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol. 2016;47(3):271–5 An international group of experts defined the US signs evident in PAS allowing a more standardised approach for clinical management and research, making studies comparable. It provides clear pictures of each sign. CrossRefPubMed
22.
Jauniaux E, Collins SL, Jurkovic D, Burton GJ. Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol. 2016;215(6):712–21.CrossRefPubMed
23.
Cramer SF, Heller DS. Placenta accreta and placenta increta: an approach to pathogenesis based on the trophoblastic differentiation pathway. Pediatr Dev Pathol. 2016;19(4):320–33.CrossRefPubMed
24.
Chantraine F, Blacher S, Berndt S, Palacios Jaraquemada JM, Sarioglu N, Nisolle M, et al. Abnormal vascular architecture at the placental-maternal interface in placenta increta. Am J Obstet Gynecol. 2012;207:188.e1–9 Available olnline 06/Jul/2012.CrossRef
25.
Matsuo K, Conturie CL, Lee RH. Snowman sign: a possible predictor of catastrophic abnormal placentation. Eur J Obstet Gynecol Reprod Biol. 2014;181:341–2.CrossRefPubMed
26.
Schaaps JP, Tsatsaris V, Goffin F, Brichant JF, Delbecque K, Tebache M, et al. Shunting the intervillous space: new concepts in human uteroplacental vascularization. Am J Obstet Gynecol. 2005;192(1):323–32.CrossRefPubMed
27.
Alfirevic Z, Tang AW, Collins SL, Robson SC, Palacios-Jaraquemada J, Ad-hoc International AIPEG. Pro forma for ultrasound reporting in suspected abnormally invasive placenta (AIP): an international consensus. Ultrasound Obstet Gynecol. 2016;47(3):276–8.CrossRefPubMed
28.
Collins SL, Alemdar B, van Beekhuizen HJ, Bertholdt C, Braun T, Calda P, et al. Evidence-based guidelines for the management of abnormally-invasive placenta (AIP): recommendations from the International Society for AIP. Am J Obstet Gynecol. 2019;220:511–26.CrossRefPubMed
29.
Jauniaux E, Ayres-De-Campos D, Langhoff- Roos J, Fox K, Collins S. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynecol Obstet. 2019;146:20–4.CrossRef
Metadata
Title
Prenatal Ultrasound Imaging for Placenta Accreta Spectrum (PAS): a Practical Guide
Authors
Frederic Chantraine
Sally L. Collins
Publication date
01-09-2019
Publisher
Springer US
Published in
Current Obstetrics and Gynecology Reports / Issue 3/2019
Electronic ISSN: 2161-3303
DOI
https://doi.org/10.1007/s13669-019-00267-8

Other articles of this Issue 3/2019

Current Obstetrics and Gynecology Reports 3/2019 Go to the issue

Aberrant Placentation: Contemporary Management of Placenta Accreta (E Jauniaux, Section Editor)

From Etiopathology to Management of Accreta Placentation

Aberrant Placentation: Contemporary Management of Placenta Accreta (E Jauniaux, Section Editor)

Is There a Role for MRI in the Management of Placenta Accreta Spectrum?

Aberrant Placentation: Contemporary Management of Placenta Accreta (E Jauniaux, Section Editor)

Multidisciplinary Teams in the Management of Placenta Accreta Spectrum Disorders

Urogynecology (P Nikpoor, Section Editor)

Broad Band Ligament Hernia Revisited (85 Cases of Allen-Master’s Syndrome; History and Perspectives)

Advances in Gynaecologic Oncology Screening Technologies (S Shanbhag, Section Editor)

Management of Induced Menopause in Gynaecological Cancers and Their Challenges

Environmental Exposures and Pregnancy Outcomes (N Grindler, Section Editor)

Paternal Environmental Toxicant Exposure and Risk of Adverse Pregnancy Outcomes